Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tiong K. Ong"'
Autor:
Stephen Jan, Stephen W-L. Lee, Jitendra P. S. Sawhney, Tiong K. Ong, Chee Tang Chin, Hyo-Soo Kim, Rungroj Krittayaphong, Vo T. Nhan, Stuart J. Pocock, Ana M. Vega, Nobuya Hayashi, Yong Huo
Publikováno v:
BMC Cardiovascular Disorders, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background The EPICOR Asia (long-tErm follow-uP of antithrombotic management patterns In acute CORonary syndrome patients in Asia) study (NCT01361386) was an observational study of patients hospitalized for acute coronary syndromes (ACS) enr
Externí odkaz:
https://doaj.org/article/395afbca940e4224919f6d57e119bcde
Autor:
Yong Huo, Stephen W Lee, Jitendra P Sawhney, Hyo-Soo Kim, Rungroj Krittayaphong, Stuart J Pocock, Vo T Nhan, Chee Tang Chin, Xiaoning Han, Ana Vega, Yohji Itoh, Tiong K Ong
Publikováno v:
Circulation. 132
Introduction: Guidelines recommend dual-antiplatelet therapy (DAPT) for 12 months in patients with acute coronary syndromes (ACS). Information on patterns and duration of DAPT use after hospital discharge in ACS patients in Asia is sparse. Objective:
Autor:
Yong, Huo, Stephen W-L, Lee, Jitendra P S, Sawhney, Hyo-Soo, Kim, Rungroj, Krittayaphong, Vo T, Nhan, Angeles, Alonso-Garcia, Ya Ling, Han, Junbo, Ge, Chee Tang, Chin, Tiong K, Ong, Stephen, Jan, Yohji, Itoh, Ana Maria, Vega, Stuart, Pocock
Publikováno v:
Clinical cardiology. 38(9)
BACKGROUND: In‐hospital and postdischarge mortality for acute coronary syndromes (ACS) vary across Asia and remain generally poorer than globally. The relationship between real‐life antithrombotic management patterns (AMPs) and ACS‐related outc
Autor:
Huo Yong, Stephen W-L. Lee, Jitendra P.S. Sawhney, Hyo-Soo Kim, Rungroj Krittayaphong, Stuart J. Pocock, Vo T. Nhan, Angeles Alonso Garcia, Chee Tang Chin, Jie Jiang, Ana Vega, Yohji Itoh, Tiong K. Ong
Publikováno v:
Journal of the American College of Cardiology. 65(10)
Real-world data on long-term outcomes after acute coronary syndrome (ACS) in China is scarce. We aimed to investigate the 2-year outcomes for Chinese patients with ACS. EPICOR Asia study ([NCT01361386][1]) was a prospective, multinational study in As
Autor:
Jan, Stephen1 sjan@georgeinstitute.org, Lee, Stephen W-L.2, Sawhney, Jitendra P. S.3, Tiong K Ong4, Chee Tang Chin5, Hyo-Soo Kim6, Krittayaphong, Rungroj7, Vo T Nhan8, Yohji Itoh9, Yong Huo10
Publikováno v:
Bulletin of the World Health Organization. Mar2016, Vol. 94 Issue 3, p193-200. 8p. 3 Charts, 3 Graphs.